camptothecin has been researched along with azidopine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AY; Liu, LF; Potmesil, M; Wall, ME; Wani, MC; Yu, C | 1 |
| Hidaka, H; Minamino, T; Miyamoto, K; Nakamura, S; Nomura, M; Wakusawa, S | 1 |
2 other study(ies) available for camptothecin and azidopine
| Article | Year |
|---|---|
Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells.
Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Camptothecin; Dihydropyridines; Drug Resistance; Humans; KB Cells; Membrane Glycoproteins; Topotecan | 1991 |
Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
Topics: Affinity Labels; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Camptothecin; Dihydropyridines; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Irinotecan; Isoquinolines; Protein Binding; Protein Kinase Inhibitors; Rats; Sulfonamides; Tritium; Tumor Cells, Cultured; Vinblastine | 1996 |